PATENT CLAIM ANALYSIS

Application Number: 16357918
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "04400A"]

Abstract:
An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 59.

Claim (Index 11):
The method of  claim 10 , wherein the antisense oligonucleotide or pharmaceutically acceptable salt thereof is chemically linked to one or more moieties or conjugates that enhance the activity, cellular distribution or cellular uptake of the oligonucleotide.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 99.0
- Lexical Diversity: 1.10345
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14944886', '14740097', '15661750', '14108137', '13509331']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.818479431817228
- 35 USC 102 Novelty (BERT): 0.7975701857247669
- Combined Prediction Score: 0.816388507207982
- Mean Citation Score: 969.5078
- Max Citation Score: 1027.9857
- Similarity Product: 978.54241186527

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test